TARRYTOWN, N.Y. & SOUTHAMPTON, England--(BUSINESS WIRE)--Siemens Medical Solutions Diagnostics (www.usa.siemens.com/medical) today announced the availability of its Enhanced Liver Fibrosis (ELF)™ test, the first CE-marked, standardized non-invasive blood test for assessing the status of liver fibrosis*. The Siemens ELF test was first validated in an international multicenter cohort study and is now available through iQur, Ltd., Southampton, UK, as a testing service for patient management.
